Fuadelhibri.ws

• Feeds

  • Entries (RSS)
  • Comments (RSS)

• You are currently browsing the archives for the Food and Drug Administration category.

• Archives

  • April 2012
  • March 2012
  • February 2012
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • January 2010
  • December 2009
  • October 2009
  • August 2009
  • July 2009

• Categories

  • Abdul Aziz Said (1)
  • American Society of Hematology (1)
  • Anthrax (6)
  • Arab (2)
  • BacilleCalmette-Guerin (1)
  • BioDefense (2)
  • biotech (1)
  • Biothrax (10)
  • Board of directors (2)
  • Business (5)
  • Chief executive officer (51)
  • Chief financial officer (1)
  • Chief Medical Officer (1)
  • Chief operating officer (1)
  • Clinical Research (1)
  • Clinical trial (2)
  • colleagues (1)
  • Dr. Mary Elizabeth King (1)
  • El-Hibri (5)
  • El-Hibri Peace Education Prize (5)
  • Emergent BioSolutions (55)
  • Entrepreneur (3)
  • Ernst & Young (1)
  • Financial Performance (1)
  • Financial Results (2)
  • Food and Drug Administration (11)
  • Foundation (2)
  • fuad el-hibri (56)
  • fuad profiles (1)
  • Health Care (5)
  • Healthcare Conference (4)
  • Infectious disease (4)
  • Investor relations (1)
  • Investors (5)
  • Lymphocytic Leukemia (1)
  • Maryland (2)
  • Music (1)
  • National Health Museum (1)
  • NATO (1)
  • Non-Hodgkin lymphoma (1)
  • North Atlantic Treaty Organization (1)
  • NuThrax (1)
  • Peace Education (3)
  • Pharmaceuticals (2)
  • Resource Center (1)
  • Revenue (1)
  • Scholars Program (1)
  • Seattle (1)
  • Share (1)
  • Shareholder (4)
  • South Africa (1)
  • TB Vaccine (1)
  • Tech Council of Maryland (1)
  • Trubion Pharmaceuticals (3)
  • Tuberculosis (2)
  • U.S. Food and Drug Administration (18)
  • Uncategorized (9)
  • United States Department of Defense (1)
  • United States Department of Health and Human Services (2)
  • Vaccine (6)
  • Washington (3)
  • Yale University (4)

Archives

Food and Drug Administration

Select Month April 2012  (1) March 2012  (1) February 2012  (2) November 2011  (1) October 2011  (3) September 2011  (2) August 2011  (2) July 2011  (2) June 2011  (4) May 2011  (2) April 2011  (3) March 2011  (2) February 2011  (2) January 2011  (2) December 2010  (2) November 2010  (2) October 2010  (2) September 2010  (2) August 2010  (4) July 2010  (5) June 2010  (2) May 2010  (2) April 2010  (1) March 2010  (2) January 2010  (1) December 2009  (3) October 2009  (2) August 2009  (2) July 2009  (8) Select Category Abdul Aziz Said  (1) American Society of Hematology  (1) Anthrax  (6) Arab  (2) BacilleCalmette-Guerin  (1) BioDefense  (2) biotech  (1) Biothrax  (10) Board of directors  (2) Business  (5) Chief executive officer  (51) Chief financial officer  (1) Chief Medical Officer  (1) Chief operating officer  (1) Clinical Research  (1) Clinical trial  (2) colleagues  (1) Dr. Mary Elizabeth King  (1) El-Hibri  (5) El-Hibri Peace Education Prize  (5) Emergent BioSolutions  (55) Entrepreneur  (3) Ernst & Young  (1) Financial Performance  (1) Financial Results  (2) Food and Drug Administration  (11) Foundation  (2) fuad el-hibri  (56) fuad profiles  (1) Health Care  (5) Healthcare Conference  (4) Infectious disease  (4) Investor relations  (1) Investors  (5) Lymphocytic Leukemia  (1) Maryland  (2) Music  (1) National Health Museum  (1) NATO  (1) Non-Hodgkin lymphoma  (1) North Atlantic Treaty Organization  (1) NuThrax  (1) Peace Education  (3) Pharmaceuticals  (2) Resource Center  (1) Revenue  (1) Scholars Program  (1) Seattle  (1) Share  (1) Shareholder  (4) South Africa  (1) TB Vaccine  (1) Tech Council of Maryland  (1) Trubion Pharmaceuticals  (3) Tuberculosis  (2) U.S. Food and Drug Administration  (18) Uncategorized  (9) United States Department of Defense  (1) United States Department of Health and Human Services  (2) Vaccine  (6) Washington  (3) Yale University  (4) Browse All

• Fuad El-Hibri Announces Emergent BioSolutionsAward to Supply BioThrax Anthrax Vaccine to U.S. Government ( October 14, 2011)
• Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule ( June 7, 2011)
• Delegates from European Parliament Express Support for Rapid Development of New TB Vaccine ( March 3, 2011)
• Emergent BioSolutions Announces Initiation of Phase Ib/II Study of TRU-016 in Combination with Bendamustine for Chronic Lymphocytic Leukemia ( February 1, 2011)
• CEO took roundabout path to Emergent ( January 7, 2011)
• Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine ( January 5, 2011)
• Fuad El-Hibri and the International Biomedical Research Alliance ( November 13, 2010)
• Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010 ( October 23, 2010)
• Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine ( September 20, 2010)
• Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine ( September 10, 2010)